Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Are there any special considerations when giving breast radiation to a patient with Sjogren's syndrome?
Do you adjust dose/fractionation?
Answer from: Radiation Oncologist at Community Practice
I have not adjusted my dose/fractionation or approach for patients with Sjogrens. I have also offered both WBI and PBI.
Sign in or Register to read more
8438
Related Questions
How do the results of INSEMA and SOUND impact the decision of omitting SLND in young women with breast cancer and offering adjuvant RT to patients who would otherwise be candidates for omission?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
What is the earliest you would start postmastectomy radiation after adjuvant chemotherapy for a patient with breast cancer?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
Is keratosis follicularis (Darier disease) a contraindication to receipt of PMRT?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?